Histamine receptor antagonists and incident colorectal adenomas

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 2, 2005, Pages 123-128

  Robertson, D J ^a,b   Burke, C A ^c   Schwender, B J ^b   Wargovich, M J ^d   Greenberg, E R ^b   Sandler, R S ^e   Ahnen, D J ^f   Rothstein, R ^b   Mott, L A ^b   Baron, J A ^b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; CALCIUM; CHLORPHENIRAMINE; CIMETIDINE; DEXTROMETHORPHAN; DIPHENHYDRAMINE; DOXYLAMINE; FAMOTIDINE; FOLIC ACID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; LORATADINE; NIZATIDINE; PARACETAMOL; PHENYLPROPANOLAMINE; PSEUDOEPHEDRINE; RANITIDINE;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTESTINE POLYP; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK REDUCTION; SEX RATIO;

ADENOMA; COLORECTAL NEOPLASMS; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TREATMENT OUTCOME;

EID: 22844436210     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02529.x     Document Type: Article

References (19)

1. Portnoy JM, Van Osdol T, Williams PB. Evidence-based strategies for treatment of allergic rhinitis. Curr Allergy Asthma Rep 2004; 4: 439-46.
2. Assanasen P, Naclerio RM. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol 2002; 17: 101-39.
3. Tytgat GN. Review article: management of mild and severe gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17 (Suppl. 2): 52-6.
4. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994; 35: 1632-6.
5. Rajendra S, Mulcahy H, Patchett S, Kumar P. The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig Dis Sci 2004; 49: 1634-40.
6. Wargovich MJ, Jimenez A, McKee K, et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 2000; 21: 1149-55.
7. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet 1994; 344: 1768-9.
8. Matsumoto S, Imaeda Y, Umemoto S, et al. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 2002; 86: 161-7.
9. Nielsen HJ, McArdle CS, Moesgaard F. The effect of ranitidine on long-term survival in primary colorectal cancer. GI Cancer 1998; 2: 227-33.
10. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994; 331: 141-7.
11. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 1999; 340: 101-7.
12. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-9.
13. Simons FE. Advances in H1-antihistamines. N Engl J Med 2004; 351: 2203-17.
14. Delvalle J, Wang L, Gantz I, Yamada T. Characterization of H2 histamine receptor: linkage to both adenylate cyclase and [Ca2+]i signaling systems. Am J Physiol 1992; 263: G967-72.
15. Wang LD, Hoeltzel M, Butler K, et al. Activation of the human histamine H2 receptor is linked to cell proliferation and c-fos gene transcription. Am J Physiol 1997; 273: C2037-45.
16. Katz PO. Optimizing medical therapy for gastroesophageal reflux disease: state of the art. Rev Gastroenterol Disord 2003; 3: 59-69.
17. Andrade SE, Gurwitz JH, Fish LS. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists. Med Care 1999; 37: 424-30.
18. Shi CW, Gralnek IM, Dulai GS, Towfigh A, Asch S. Consumer usage patterns of nonprescription histamine2-receptor antagonists. Am J Gastroenterol 2004; 99: 606-10.
19. Tilly BC, Tertoolen LG, Remorie R, et al. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors. J Cell Biol 1990; 110: 1211-5.